Indeed, patient data support this notion since PDAC patients harboring TP53 R248Q or TP53 R248W mutations showed a trend for reduced survival compared to patients with loss-of-function NS+FS mutation ( Figure 5E ), supporting the mutp53 R248W -pSTAT3 complex as a potentially attractive target in PDAC.
← all excerpts
The Gain-of-Function p53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells.
1
—
—